-
In April 2025, the National Cancer Control Programme (NCCP) published new evidence-based recommendations on the active...
-
NSCLC. For the first time, a large prospective randomised trial has demonstrated that a 14-gene molecular...
-
Focal therapy. In addition to new recommendations on active surveillance of patients with prostate cancer, the...
-
Breast cancer. The SERENA-6 phase 3 trial has reported that camizestrant in combination with a CDK...
-
Small cell lung cancer. Results from a global phase 3 clinical trial found that maintenance therapy...
-
The American Society of Clinical Oncology (ASCO), in collaboration with Google Cloud, has launched an AI-based...
-
Patients with chronic conditions are known to be higher users of complementary and alternative medicine (CAM)...
-
PsA. There are limited data on outcomes when switching treatment directly from tumour necrosis factor inhibitor...
-
ED. Older patients living with frailty who receive a comprehensive geriatrician-led assessment (CGA) on presentation to...
-
In April 2025, the British Society for Rheumatology (BSR) published new guidelines on the treatment of...
-
Pleural mesothelioma. New findings from the European Thoracic Oncology Platform (ETOP) Mesoscape project suggest the immunoregulatory...
-
T-cell. Research led by the Centre for Experimental Pathogen Host Research (CEPHR) at University College Dublin...
ADVERTISEMENT
ADVERTISEMENT